iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution
20 nov. 2023 08h00 HE
|
iCAD, Inc.
Offering radiology the most complete breast health solution, including breast density assessment, breast cancer detection, and thorough risk evaluation, including lifetime, genetic, and short-term 1-...
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
14 nov. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
iCAD Reports Financial Results for Third Quarter Ended September 30, 2023
13 nov. 2023 16h01 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
30 oct. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta
23 oct. 2023 08h01 HE
|
iCAD, Inc.
NASHUA, N.H., Oct. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions announced today that Elekta...
Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment
16 août 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Health...
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
14 août 2023 16h01 HE
|
iCAD, Inc.
NASHUA, N.H., Aug. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its...
iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader
14 août 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Aug. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it signed...
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
31 juil. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., July 31, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will...
iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice
18 juil. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., July 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it has...